Bangkok Genomics Innovation PCL (BKK:BKGI)
Thailand · Delayed Price · Currency is THB 2.380
0.00 (0.00%)
Sep 11, 2026, 4:36 PM ICT
BKK:BKGI Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 538.69 | 379.51 | 337.59 | 245.39 | 304.77 | |
Revenue Growth | 62.34% | 12.42% | 37.57% | -19.48% | - |
Cost of Revenue | 319.52 | 223.88 | 197.52 | 129.29 | 147.26 |
Gross Profit | 219.17 | 155.63 | 140.08 | 116.1 | 157.52 |
Selling, General & Admin | 115.67 | 111.36 | 94.5 | 85.22 | 93.97 |
Other Operating Expenses | -5.06 | -7.22 | -8.27 | -1.95 | -15.29 |
Operating Expenses | 113.65 | 106.01 | 87.61 | 82.52 | 77.78 |
Operating Income | 105.52 | 49.62 | 52.46 | 33.58 | 79.73 |
Interest Expense | -1.36 | -1.44 | -1.36 | -1.64 | -1.07 |
Earnings From Equity Investments | -0.15 | -0.32 | -0.08 | - | - |
Pretax Income | 104.02 | 47.85 | 51.02 | 31.94 | 78.66 |
Income Tax Expense | 9.05 | 2.52 | 0.86 | -0.2 | 3.54 |
Earnings From Continuing Operations | 94.97 | 45.33 | 50.16 | 32.14 | 75.11 |
Minority Interest in Earnings | 0.1 | 0.02 | 0.01 | - | - |
Net Income | 95.06 | 45.35 | 50.17 | 32.14 | 75.11 |
Net Income to Common | 95.06 | 45.35 | 50.17 | 32.14 | 75.11 |
Net Income Growth | 142.97% | -9.61% | 56.09% | -57.21% | - |
Shares Outstanding (Basic) | 600 | 600 | 567 | 440 | 214 |
Shares Outstanding (Diluted) | 600 | 600 | 567 | 440 | 214 |
Shares Change | -0.03% | 5.78% | 28.91% | 105.72% | - |
EPS (Basic) | 0.16 | 0.08 | 0.09 | 0.07 | 0.35 |
EPS (Diluted) | 0.16 | 0.08 | 0.09 | 0.07 | 0.35 |
EPS Growth | 143.04% | -14.55% | 21.09% | -79.20% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -57.37 | -107.41 | -23.46 | 67.03 | 53.9 |
Free Cash Flow Per Share | -0.10 | -0.18 | -0.04 | 0.15 | 0.25 |
Dividend Per Share | 0.050 | 0.050 | 0.050 | 0.054 | 4.666 |
Dividend Growth | 0% | 0% | -8.26% | -98.83% | - |
Gross Margin | 40.69% | 41.01% | 41.49% | 47.31% | 51.68% |
Operating Margin | 19.59% | 13.07% | 15.54% | 13.69% | 26.16% |
Profit Margin | 17.65% | 11.95% | 14.86% | 13.10% | 24.64% |
Free Cash Flow Margin | -10.65% | -28.30% | -6.95% | 27.31% | 17.68% |
EBITDA | 122.97 | 65.58 | 64.83 | 44.16 | 88.82 |
EBITDA Margin | 22.83% | 17.28% | 19.20% | 18.00% | 29.14% |
D&A For EBITDA | 17.45 | 15.96 | 12.37 | 10.57 | 9.08 |
EBIT | 105.52 | 49.62 | 52.46 | 33.58 | 79.73 |
EBIT Margin | 19.59% | 13.07% | 15.54% | 13.69% | 26.16% |
Effective Tax Rate | 8.70% | 5.27% | 1.69% | - | 4.51% |
Revenue as Reported | 538.69 | 379.51 | 337.59 | 245.39 | 304.77 |